Lorad of Danbury, CT, will show its latest developments in bothscreen-film and digital mammography in its RSNA booth. On theconventional side, Lorad will introduce M-IV, its newest mammographyplatform and successor to M-III (SCAN 10/11/95). M-IV's high
Lorad of Danbury, CT, will show its latest developments in bothscreen-film and digital mammography in its RSNA booth. On theconventional side, Lorad will introduce M-IV, its newest mammographyplatform and successor to M-III (SCAN 10/11/95).
M-IV's high transmission cellular grid system (HTC) improvescontrast in screen-film mammography at an equal or lower radiationdose than conventional systems, according to Hal Kirshner, presidentof Lorad and ThermoTrex Medical. It should prove particularlyuseful for imaging patients with dense breasts, Kirshner said.HTC will be available as an option on M-IV units.
Lorad will also reveal its latest work in full-view digital mammography.The company will show patient images acquired with a system beingused by Dr. Laurie Fajardo at the University of Virginia.
In addition, the company has adapted its StereoLoc prone digitalbreast biopsy technology for its upright mammography systems.Lorad will also display a line of radiographic equipment beingdeveloped for the firm by Bennett X-Ray, its new sister company.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.